Autonomic imbalance: prophet of doom or scope for hope?

Abstract

Diabet. Med. 28, 643–651 (2011) It has long been recognized that cardiac autonomic neuropathy increases morbidity and mortality in diabetes and may have greater predictive power than traditional risk factors for cardiovascular events. Significant morbidity and mortality can now be attributable to autonomic imbalance between the sympathetic and parasympathetic nervous system regulation of cardiovascular function. New and emerging syndromes include orthostatic tachycardia, orthostatic bradycardia and an inability to use heart rate as a guide to exercise intensity because of the resting tachycardia. Recent studies have shown that autonomic imbalance may be a predictor of risk of sudden death with intensification of glycaemic control. This review examines an association of autonomic dysregulation and the role of inflammatory cytokines and adipocytokines that promote cardiovascular risk. In addition, conditions of autonomic imbalance associated with cardiovascular risk are discussed. Potential treatment for restoration of autonomic balance is outlined.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 80

1. 1.

   Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115:387-397.

   Not in our library10.1161/circulationaha.106.634949

2. 2.

   Ondicova K, Mravec B. Multilevel interactions between the sympathetic and parasympathetic nervous systems: a mini-review. Endocr Regul. 2010;44:69-75.

   Not in our library10.4149/endo_2010_02_69

3. 3.

   Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553-1579.

   Not in our library10.2337/diacare.26.5.1553

4. 4.

   Diabetes Control, Complications Trial. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia. 1998;41:416-423.

   Not in our library10.1007/s001250050924

5. 5.

   Kennedy WR, Navarro X, Sutherland DE. Neuropathy profile of diabetic patients in a pancreas transplantation program. Neurology. 1995;45:773-780.

   Not in our library10.1212/wnl.45.4.773

6. 6.

   Ziegler D, Gries FA, Muhlen H, Rathmann W, Spuler M, Lessmann F. Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group. Diabetes Metab. 1993;19:143-151.

   Not in our library

7. 7.

   Wu JS, Yang YC, Lin TS, Huang YH, Chen JJ, Lu FH, et al. Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose. J Clin Endocrinol Metab. 2007;92:3885-3889.

   Not in our library10.1210/jc.2006-2175

8. 8.

   Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003;26:1895-1901.

   Not in our library10.2337/diacare.26.6.1895

9. 9.

   Beijers HJ, Ferreira I, Bravenboer B, Dekker JM, Nijpels G, Heine RJ, et al. Microalbuminuria and cardiovascular autonomic dysfunction are independently associated with cardiovascular mortality: evidence for distinct pathways: the Hoorn Study. Diabetes Care. 2009;32:1698-1703.

   Not in our library10.2337/dc08-1544

10. 10.

    Ziegler D, Zentai CP, Perz S, Rathmann W, Haastert B, Doring A, et al. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and non-diabetic population: the MONICA/KORA Augsburg Cohort Study. Diabetes Care. 2008;31:556-561.

    Not in our library10.2337/dc07-1615

11. 11.

    Orchard TJ, Lloyd CE, Maser RE, Kuller LH. Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Res Clin Pract. 1996;34:S165-S171.

    Not in our library10.1016/s0168-8227(96)90025-x

12. 12.

    Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL, et al. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation. 2009;119:2886-2893.

    Not in our library10.1161/circulationaha.108.837369

13. 13.

    White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr. 2001;139:804-812.

    Not in our library10.1067/mpd.2001.118887

14. 14.

    Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-393.

    Not in our library10.1056/nejmoa021778

15. 15.

    Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580-591.

    Not in our library10.1056/nejmoa0706245

16. 16.

    Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129-139.

    Not in our library10.1056/nejmoa0808431

17. 17.

    LeRoith D, Fonseca V, Vinik A. Metabolic memory in diabetes—focus on insulin. Diabetes Metab Res Rev. 2005;21:85-90.

    Not in our library10.1002/dmrr.530

18. 18.

    Casellini CM, Barlow PM, Rice AL, Casey M, Simmons K, Pittenger G, et al. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-β inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy. Diabetes Care. 2007;30:896-902.

    Not in our library10.2337/dc06-1699

19. 19.

    Ceriello A, Esposito K, Ihnat M, Thorpe J, Giugliano D. Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes. J Clin Endocrinol Metab. 2009;94:2751-2756.

    Not in our library10.1210/jc.2009-0762

20. 20.

    Cumbie BC, Hermayer KL. Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications. Vasc Health Risk Manag. 2007;3:823-832.

    Not in our library

21. 21.

    Witte DR, Tesfaye S, Chaturvedi N, Eaton SE, Kempler P, Fuller JH. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia. 2005;48:164-171.

    Not in our library10.1007/s00125-004-1617-y

22. 22.

    Stella P, Ellis D, Maser RE, Orchard TJ. Cardiovascular autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes. Incidence and predictors. J Diabetes Complications. 2000;14:1-6.

    Not in our library10.1016/s1056-8727(00)00054-4

23. 23.

    Kles KA, Vinik AI. Pathophysiology and treatment of diabetic peripheral neuropathy: the case for diabetic neurovascular function as an essential component. Curr Diabetes Rev. 2006;2:131-145.

    Not in our library10.2174/157339906776818569

24. 24.

    Lampert R, Bremner JD, Su S, Miller A, Lee F, Cheema F, et al. Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. Am Heart J. 2008;156:759-757.

    Not in our library10.1016/j.ahj.2008.07.009

25. 25.

    Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405:458-462.

    Not in our library10.1038/35013070

26. 26.

    Mohamed-Ali V, Flower L, Sethi J, Hotamisligil G, Gray R, Humphries SE, et al. β-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J Clin Endocrinol Metab. 2001;86:5864-5869.

    Not in our library10.1210/jcem.86.12.8104

27. 27.

    Soszynski D, Kozak W, Conn CA, Rudolph K, Kluger MJ. β-Adrenoceptor antagonists suppress elevation in body temperature and increase in plasma IL-6 in rats exposed to open field. Neuroendocrinology. 1996;63:459-467.

    Not in our library10.1159/000127072

28. 28.

    Herder C, Lankisch M, Ziegler D, Rathmann W, Koenig W, Illig T, et al. Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany). Diabetes Care. 2009;32:680-682.

    Not in our library10.2337/dc08-2011

29. 29.

    Carlyle M, Jones OB, Kuo JJ, Hall JE. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension. 2002;39:496-501.

    Not in our library10.1161/hy0202.104398

30. 30.

    Paolisso G, Manzella D, Montano N, Gambardella A, Varricchio M. Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights. J Clin Endocrinol Metab. 2000;85:1810-1814.

    Not in our library10.1210/jcem.85.5.6511

31. 31.

    Murialdo G, Casu M, Falchero M, Brugnolo A, Patrone V, Cerro PF, et al. Alterations in the autonomic control of heart rate variability in patients with anorexia or bulimia nervosa: correlations between sympathovagal activity, clinical features, and leptin levels. J Endocrinol Invest. 2007;30:356-362.

    Not in our library10.1007/bf03346310

32. 32.

    Rosenbaum M, Goldsmith R, Bloomfield D, Magnano A, Weimer L, Heymsfield S, et al. Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest. 2005;115:3579-3586.

    Not in our library10.1172/jci25977

33. 33.

    da Costa Goncalves AC, Tank J, Diedrich A, Hilzendeger A, Plehm R, Bader M, et al. Diabetic hypertensive leptin receptor-deficient db/db mice develop cardioregulatory autonomic dysfunction. Hypertension. 2009;53:387-392.

    Not in our library10.1161/hypertensionaha.108.124776

34. 34.

    Imai J, Katagiri H, Yamada T, Ishigaki Y, Ogihara T, Uno K, et al. Cold exposure suppresses serum adiponectin levels through sympathetic nerve activation in mice. Obesity (Silver Spring). 2006;14:1132-1141.

    Not in our library10.1038/oby.2006.130

35. 35.

    Wakabayashi S, Aso Y. Adiponectin concentrations in sera from patients with type 2 diabetes are negatively associated with sympathovagal balance as evaluated by power spectral analysis of heart rate variation. Diabetes Care. 2004;27:2392-2397.

    Not in our library10.2337/diacare.27.10.2392

36. 36.

    Hoyda TD, Samson WK, Ferguson AV. Adiponectin depolarizes parvocellular paraventricular nucleus neurons controlling neuroendocrine and autonomic function. Endocrinology. 2009;150:832-840.

    Not in our library10.1210/en.2008-1179

37. 37.

    Hoyda TD, Smith PM, Ferguson AV. Adiponectin acts in the nucleus of the solitary tract to decrease blood pressure by modulating the excitability of neuropeptide Y neurons. Brain Res. 2009;1256:76-84.

    Not in our library10.1016/j.brainres.2008.12.012

38. 38.

    Tanida M, Shen J, Horii Y, Matsuda M, Kihara S, Funahashi T, et al. Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats. Exp Biol Med (Maywood). 2007;232:390-397.

    Not in our library

39. 39.

    Kreier F, Fliers E, Voshol PJ, Van Eden CG, Havekes LM, Kalsbeek A, et al. Selective parasympathetic innervation of subcutaneous and intra-abdominal fat—functional implications. J Clin Invest. 2002;110:1243-1250.

    Not in our library10.1172/jci15736

40. 40.

    Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315-424.

    Not in our library10.1152/physrev.00029.2006

41. 41.

    Szabo C, Mabley JG, Moeller SM, Shimanovich R, Pacher P, Virag L, et al. Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol Med. 2002;8:571-580.

    Not in our library

42. 42.

    Virag L, Szabo E, Gergely P, Szabo C. Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett. 2003;141:113-124.

    Not in our library10.1016/s0378-4274(02)00508-8

43. 43.

    Obrosova IG, Drel VR, Oltman CL, Mashtalir N, Tibrewala J, Groves JT, et al. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats. Am J Physiol Endocrinol Metab. 2007;293:E1645-E1655.

    Not in our library10.1152/ajpendo.00479.2007

44. 44.

    Ziegler D, Sohr CG, Nourooz-Zadeh J. Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care. 2004;27:2178-2183.

    Not in our library10.2337/diacare.27.9.2178

45. 45.

    Ceriello A, Assaloni R, Da RR, Maier A, Quagliaro L, Piconi L, et al. Effect of irbesartan on nitrotyrosine generation in non-hypertensive diabetic patients. Diabetologia. 2004;47:1535-1540.

    Not in our library10.1007/s00125-004-1487-3

46. 46.

    Vinik A, Parson H, Ullal J. The role of PPARs in the microvascular dysfunction in diabetes. Vascul Pharmacol. 2006;45:54-64.

    Not in our library10.1016/j.vph.2005.11.012

47. 47.

    Julius U, Drel VR, Grassler J, Obrosova IG. Nitrosylated proteins in monocytes as a new marker of oxidative–nitrosative stress in diabetic subjects with macroangiopathy. Exp Clin Endocrinol Diabetes. 2009;117:72-77.

    Not in our library10.1055/s-2008-1078710

48. 48.

    Kellogg AP, Converso K, Wiggin T, Stevens M, Pop-Busui R. Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes. Am J Physiol Heart Circ Physiol. 2009;296:H453-H461.

    Not in our library10.1152/ajpheart.00678.2008

49. 49.

    Petrova M, Townsend R, Teff KL. Prolonged (48-h) modest hyperinsulinemia decreases nocturnal heart rate variability and attenuates the nocturnal decrease in blood pressure in lean, normotensive humans. J Clin Endocrinol Metab. 2006;91:851-859.

    Not in our library10.1210/jc.2005-1752

50. 50.

    Ziegler D, Zentai C, Perz S, Rathmann W, Haastert B, Meisinger C, et al. Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. Exp Clin Endocrinol Diabetes. 2006;114:153-159.

    Not in our library10.1055/s-2006-924083

51. 51.

    Licht CM, Vreeburg SA, van Reedt Dortland AK, Giltay EJ, Hoogendijk WJ, Derijk RH, et al. Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic–pituitary–adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab. 2010;95:2458-2466.

    Not in our library10.1210/jc.2009-2801

52. 52.

    Chang CJ, Yang YC, Lu FH, Lin TS, Chen JJ, Yeh TL, et al. Altered cardiac autonomic function may precede insulin resistance in metabolic syndrome. Am J Med. 2010;123:432-438.

    Not in our library10.1016/j.amjmed.2009.07.031

53. 53.

    Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension. 2003;42:474-480.

    Not in our library10.1161/01.hyp.0000091371.53502.d3

54. 54.

    Carnethon MR, Jacobs DR, Sidney S, Liu K. Influence of autonomic nervous system dysfunction on the development of type 2 diabetes: the CARDIA study. Diabetes Care. 2003;26:3035-3041.

    Not in our library10.2337/diacare.26.11.3035

55. 55.

    Bottini P, Redolfi S, Dottorini ML, Tantucci C. Autonomic neuropathy increases the risk of obstructive sleep apnea in obese diabetics. Respiration. 2008;75:265-271.

    Not in our library10.1159/000100556

56. 56.

    Reynolds EB, Seda G, Ware JC, Vinik AI, Risk MR, Fishback NF. Autonomic function in sleep apnea patients: increased heart rate variability except during REM sleep in obese patients. Sleep Breath. 2007;11:53-60.

    Not in our library10.1007/s11325-006-0083-9

57. 57.

    West SD, Nicoll DJ, Stradling JR. Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax. 2006;61:945-950.

    Not in our library10.1136/thx.2005.057745

58. 58.

    Bottini P, Dottorini ML, Cristina CM, Casucci G, Tantucci C. Sleep-disordered breathing in non-obese diabetic subjects with autonomic neuropathy. Eur Respir J. 2003;22:654-660.

    Not in our library10.1183/09031936.03.00070402

59. 59.

    Narkiewicz K, Somers VK. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand. 2003;177:385-390.

    Not in our library10.1046/j.1365-201x.2003.01091.x

60. 60.

    Aytemir K, Deniz A, Yavuz B, Ugur DA, Sahiner L, Ciftci O, et al. Increased myocardial vulnerability and autonomic nervous system imbalance in obstructive sleep apnea syndrome. Respir Med. 2007;101:1277-1282.

    Not in our library10.1016/j.rmed.2006.10.016

61. 61.

    Adlakha A, Shephard JW. Cardiac arrythmias during normal sleep and in obstructive sleep apnea syndrome. Sleep Med Rev. 1998;2:45-60.

    Not in our library10.1016/s1087-0792(98)90053-3

62. 62.

    Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea–hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046-1053.

    Not in our library10.1016/s0140-6736(05)71141-7

63. 63.

    Gami AS, Howard DE, Olson EJ, Somers VK. Day–night pattern of sudden death in obstructive sleep apnea. N Engl J Med. 2005;352:1206-1214.

    Not in our library10.1056/nejmoa041832

64. 64.

    Tasali E, Ip MS. Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc. 2008;5:207-217.

    Not in our library10.1513/pats.200708-139mg

65. 65.

    Tuomilehto H, Peltonen M, Partinen M, Seppa J, Saaristo T, Korpi-Hyovalti E, et al. Sleep duration is associated with an increased risk for the prevalence of type 2 diabetes in middle-aged women – The FIN-D2D survey. Sleep Med. 2008;9:221-227.

    Not in our library10.1016/j.sleep.2007.04.015

66. 66.

    Maser RE, Lenhard MJ, Rizzo AA, Vasile AA. Continuous positive airway pressure therapy improves cardiovascular autonomic function for persons with sleep-disordered breathing. Chest. 2008;133:86-91.

    Not in our library10.1378/chest.07-1580

67. 67.

    Craig S, Pepperell JC, Kohler M, Crosthwaite N, Davies RJ, Stradling JR. Continuous positive airway pressure treatment for obstructive sleep apnoea reduces resting heart rate but does not affect dysrhythmias: a randomised controlled trial. J Sleep Res. 2009;18:329-336.

    Not in our library10.1111/j.1365-2869.2008.00726.x

68. 68.

    Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest. 1993;91:819-828.

    Not in our library10.1172/jci116302

69. 69.

    Adler GK, Bonyhay I, Failing H, Waring E, Dotson S, Freeman R. Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control. Diabetes. 2009;58:360-366.

    Not in our library10.2337/db08-1153

70. 70.

    Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545-2559.

    Not in our library10.1056/nejmoa0802743

71. 71.

    Pop-Busui R, Evans G, Gerstein H, Fonseca V, Fleg J, Hoogwerf B, et al. Effects of cardiac autonomic dysfunction on mortality risk in the action to control cardiovascular risk in diabetes (ACCORD) trial. Diabetes Care. 2010;33:1578-1584.

    Not in our library10.2337/dc10-0125

72. 72.

    Carnethon MR, Prineas RJ, Temprosa M, Zhang ZM, Uwaifo G, Molitch ME. The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. Diabetes Care. 2006;29:914-919.

    Not in our library10.2337/diacare.29.04.06.dc05-1729

73. 73.

    Colberg S, Swain D, Vinik A. Use of heart rate reserve and rating of perceived exertion to prescribe exercise intensity in diabetic autonomic neuropathy. Diabetes Care. 2003;26:986-990.

    Not in our library10.2337/diacare.26.4.986

74. 74.

    Colberg SR, Stansberry KB, McNitt PM, Vinik AI. Chronic exercise is associated with enhanced cutaneous blood flow in type 2 diabetes. J Diabetes Complications. 2002;16:139-145.

    Not in our library10.1016/s1056-8727(01)00222-7

75. 75.

    Michalsen A, Knoblauch NT, Lehmann N, Grossman P, Kerkhoff G, Wilhelm FH, et al. Effects of lifestyle modification on the progression of coronary atherosclerosis, autonomic function, and angina—the role of GNB3 C825T polymorphism. Am Heart J. 2006;151:870-877.

    Not in our library10.1016/j.ahj.2005.06.025

76. 76.

    Howorka K, Pumprla J, Haber P, Koller-Strametz J, Mondrzyk J, Schabmann A. Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy. Cardiovasc Res. 1997;34:206-214.

    Not in our library10.1016/s0008-6363(97)00040-0

77. 77.

    Motooka M, Koike H, Yokoyama T, Kennedy NL. Effect of dog-walking on autonomic nervous activity in senior citizens. Med J Aust. 2006;184:60-63.

    Not in our library10.5694/j.1326-5377.2006.tb00116.x

78. 78.

    Ziegler D, Schatz H, Conrad F, Gries FA, Ulrich H, Reichel G. Effects of treatment with the antioxidant α-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care. 1997;20:369-373.

    Not in our library10.2337/diacare.20.3.369

79. 79.

    Ziegler D, Weise F, Langen KJ, Piolot R, Boy C, Hubinger A, et al. Effect of glycaemic control on myocardial sympathetic innervation assessed by metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients. Diabetologia. 1998;41:443-451.

    Not in our library10.1007/s001250050928

80. 80.

    Colombo J, Iffrig K, Aysin E, Aysin B, Vinik A. Sympathetic/parasympathetic imbalance is associated with symptoms of orthostasis. Diabetes. 2007;56:A613.

    Not in our library

Cited by papers we hold 3

• Moderate intensity exercise improves heart rate variability in obese adults with type 2 diabetes · 2018
  Not checked
• Heart Rate Variability, Insulin Resistance, and Insulin Sensitivity in Japanese Adults: The Toon Health Study · 2015
  Not checked
• Impact of Diabetes on Cardiovascular Disease: An Update · 2013
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.